Sociedad Científica: Sociedad Española de Medicina Preventiva; Salud Pública y Gestión Sanitaria (SEMPSPGS)
Hagiya H, Otsuka F. Increased evidence for no benefit of contact precautions in preventing extended-spectrum β-lactamases-producing Enterobacteriaceae: Systematic scoping review. Am J Infect Control. 2023;51(9):1056-62. doi: 10.1016/j.ajic.2023.01.018. PMID: 36736903.
Thompson P, Teter J, Atrubin K. Incidence of health care-associated extended-spectrum β-lactamase-positive patients before and after discontinuation of contact precautions. Am J Infect Control. 2020;48(1):52-5. doi: 10.1016/j.ajic.2019.06.016. PMID: 31358415.
Maechler F, Schwab F, Hansen S, Fankhauser C, Harbarth S, Huttner BD, Diaz-Agero C, Lopez N, Canton R, Ruiz-Garbajosa P, Blok H, Bonten MJ, Kloosterman F, Schotsman J, Cooper BS, Behnke M, Golembus J, Kola A, Gastmeier P; R-GNOSIS WP5 study group. Contact isolation versus standard precautions to decrease acquisition of extended-spectrum β-lactamase-producing Enterobacterales in non-critical care wards: a cluster-randomised crossover trial. Lancet Infect Dis. 2020;20(5):575-84. doi: 10.1016/S1473-3099(19)30626-7. PMID: 32087113.
Gottlieb LB, Walits E, Patel G, Schaefer S. Taking off the gown: Impact of discontinuing contact precautions for extended-spectrum β-lactamase (ESBL)-producing organisms. Antimicrob Steward Healthc Epidemiol. 2021;1(1):e31. doi: 10.1017/ash.2021.189. PMID: 36168477; PMCID: PMC9495408.
Kluytmans-van den Bergh MFQ, Bruijning-Verhagen PCJ, Vandenbroucke-Grauls CMJE, de Brauwer EIGB, Buiting AGM, Diederen BM, van Elzakker EPM, Friedrich AW, Hopman J, Al Naiemi N, Rossen JWA, Ruijs GJHM, Savelkoul PHM, Verhulst C, Vos MC, Voss A, Bonten MJM, Kluytmans JAJW; SoM Study Group. Contact precautions in single-bed or multiple-bed rooms for patients with extended-spectrum β-lactamase-producing Enterobacteriaceae in Dutch hospitals: a cluster-randomised, crossover, non-inferiority study. Lancet Infect Dis. 2019;19(10):1069-79. doi: 10.1016/S1473-3099(19)30262-2. PMID: 31451419.
Souverein D, Euser SM, Herpers BL, Hattink C, Houtman P, Popma A, Kluytmans J, Rossen JWA, Den Boer JW. No nosocomial transmission under standard hygiene precautions in short term contact patients in case of an unexpected ESBL or Q&A E. coli positive patient: a one-year prospective cohort study within three regional hospitals. Antimicrob Resist Infect Control. 2017;6:69. doi: 10.1186/s13756-017-0228-6. PMID: 28670449; PMCID: PMC5485576.
Tschudin-Sutter S, Lucet JC, Mutters NT, Tacconelli E, Zahar JR, Harbarth S. Contact Precautions for Preventing Nosocomial Transmission of Extended-Spectrum β Lactamase-Producing Escherichia coli: A Point/Counterpoint Review. Clin Infect Dis. 2017;65(2):342-7. doi: 10.1093/cid/cix258. PMID: 28379311.
Tschudin-Sutter S, Frei R, Schwahn F, Tomic M, Conzelmann M, Stranden A, Widmer AF. Prospective Validation of Cessation of Contact Precautions for Extended-Spectrum β-Lactamase-Producing Escherichia coli(1). Emerg Infect Dis. 2016 Jun;22(6):1094-7. doi: 10.3201/eid2206.150554. PMID: 27191171; PMCID: PMC4880108.
Metan G, Metin BC, Baştuğ Z, Tekin İ, Aytaç H, Çınar B, Zengin H, Ünal S. Cessation of Contact Precautions for Extended-Spectrum Beta-Lactamase (ESBL)-Producing Escherichia coli Seems to be Safe in a Nonepidemic Setting. Infect Control Hosp Epidemiol. 2017;38(11):1379-81. doi: 10.1017/ice.2017.198. Epub 2017 Sep 20. PMID: 28927480.
Zahar JR, Poirel L, Dupont C, Fortineau N, Nassif X, Nordmann P. About the usefulness of contact precautions for carriers of extended-spectrum beta-lactamase-producing Escherichia coli. BMC Infect Dis. 2015;15:512. doi: 10.1186/s12879-015-1244-x. PMID: 26563141; PMCID: PMC4642679.
Bellini C, Eder M, Senn L, Sommerstein R, Vuichard-Gysin D, Schmiedel Y, Schlegel M, Harbarth S, Troillet N. Providing care to patients in contact isolation: is the systematic use of gloves still indicated? Swiss Med Wkly. 2022;152:w30110. doi: 10.4414/smw.2022.w30110. PMID: 35147391.
